Lessons Unlearned
The COVID-19 pandemic exposed fundamental weaknesses in America's public health infrastructure, supply chain resilience, and governmental coordination. Three years later, many of these weaknesses persist. Pandemic preparedness funding has waned, public health workforce attrition has accelerated, and the political polarization that hampered the COVID response has not improved.
The probability of another pandemic-scale health emergency before 2029 is not negligible. Novel pathogens continue to emerge from animal-to-human transmission, laboratory accidents remain a risk, and the global surveillance system has gaps that could delay detection of a new threat.
Current Capabilities
Surveillance: The CDC's disease surveillance capabilities have been modernized in some areas but remain fragmented. Genomic sequencing capacity has expanded dramatically thanks to COVID-era investment, but the integration of surveillance data across federal, state, and local systems remains incomplete.
Medical countermeasures: The mRNA vaccine platform developed during COVID provides a rapid-response capability for new pathogens. The ability to design, test, and manufacture vaccines has been compressed from years to months. However, distribution and public acceptance remain challenges.
Stockpiles: The Strategic National Stockpile has been replenished after COVID-era depletion, but the adequacy of stockpile levels depends on the nature and scale of the next threat.
Hospital capacity: The US healthcare system continues to operate near capacity under normal conditions, with limited surge capacity for a pandemic-scale emergency. The nurse and physician shortages exacerbated by COVID have not been resolved.
Emerging Threats
Avian influenza: H5N1 and other avian influenza strains continue to circulate in bird and mammalian populations, with sporadic human infections raising concern about the potential for a pandemic strain to emerge.
Novel coronaviruses: The SARS-CoV-2 family of viruses continues to evolve, and new coronaviruses from animal reservoirs remain a persistent threat.
Antimicrobial resistance: The growing prevalence of antibiotic-resistant bacteria represents a slow-moving but potentially devastating health crisis that could render common infections untreatable.
Our Assessment
Our prediction market assigns a 15% probability to a new pandemic (non-COVID) causing more than 10,000 US deaths before 2029. This probability reflects both the genuine epidemiological risks and the improved, if imperfect, preparedness capabilities developed during the COVID era.
Political Preparedness
Perhaps the greatest vulnerability is political. The politicization of public health measures during COVID has created an environment where future pandemic responses will face immediate partisan resistance, regardless of the scientific evidence. Rebuilding public trust in public health institutions is essential for effective pandemic preparedness.